Ambit Canada Inc.
Toronto, ON
Company Overview
Ambit discovers and develops novel drugs aimed at important diseases in the areas of stroke and other CNS disorders, cancer, and inflammation. Our lead drug candidates include neuroprotectants for treatment of stroke and other CNS disorders and kinase inhibitors for treatment of cancer and inflammatory diseases.
Company Information
Physical Address
MaRS Centre, South Tower, 200-101 College St
Toronto, ON M5G 1L7
CA
Mailing Address
MaRS Centre, South Tower, 200-101 College St
Toronto, ON M5G 1L7
CA
Additional Details
Legal Name: Ambit Canada Inc.
Country of Ownership:
CA
Contacts
Products
- Kinase Inhibitors
NAICS Categories
- 325410 Pharmaceutical and Medicine Manufacturing
- 541710 Research and Development in the Physical, Engineering and Life Sciences
Additional Information
NAICS:
325410, 541710